EXHIBIT 4.1

                                     WARRANT

NEITHER  THE  WARRANTS  REPRESENTED  HEREBY  NOR THE  SECURITIES  ISSUABLE  UPON
EXERCISE  THEREOF HAVE BEEN  REGISTERED  UNDER THE  SECURITIES  ACT OF 1933,  AS
AMENDED  (THE  "ACT").  NONE OF SUCH  SECURITIES  MAY BE OFFERED OR SOLD  EXCEPT
PURSUANT  TO (I) AN  EFFECTIVE  REGISTRATION  STATEMENT,  OR (II)  AN  AVAILABLE
EXEMPTION  FROM  REGISTRATION  UNDER  THE ACT  RELATING  TO THE  DISPOSITION  OF
SECURITIES AND UPON DELIVERY TO THE COMPANY OF AN OPINION OF COUNSEL, REASONABLY
SATISFACTORY TO COUNSEL FOR THE COMPANY,  THAT SUCH EXEMPTION FROM  REGISTRATION
UNDER THE ACT IS AVAILABLE.

DATE:  June 30, 1999
NO.: W-8

                               WARRANT TO PURCHASE
                                    SHARES OF
                                  COMMON STOCK
                                       OF
                                  EGLOBE, INC.

         eGlobe, Inc., a Delaware corporation (the "Company"),  hereby issues to
EXTL  Investors,  LLC (the  "Holder") this warrant to purchase from the Company,
for a price per share equal to $1.00,  5,000,000  shares of common stock,  $.001
par value per share of the Company (the "Common Stock").

         1. Exercise.  The rights  represented by this warrant may be exercised,
in whole or in part, at any time beginning on (i) the date hereof,  with respect
to  one-third  (1/3) of the number of shares of Common Stock which the Holder is
entitled  to  purchase  under this  warrant,  (ii) the  earlier of (x) the first
anniversary of the date hereof and (y) the Note Maturity Date, as defined in the
Loan and Note Purchase  Agreement,  dated as of April 9, 1999, among the Holder,
the Company and eGlobe Financing  Corporation,  a wholly owned subsidiary of the
Company and amended by Amendment No. 1 to Loan and Note Purchase Agreement dated
as of the date hereof (the "Loan and Note Purchase Agreement"),  with respect to
an additional  one-third (1/3) of the number of shares of Common Stock which the
Holder is entitled to purchase under this warrant,  and (iii) the earlier of (x)
the second  anniversary of the date hereof and (y) the Note Maturity Date,  with
respect to the final  one-third  (1/3) of the  number of shares of Common  Stock
which the Holder is entitled to purchase under this warrant,  in each case until
(and all rights to purchase Common Stock hereunder shall expire at) 5:00 PM (New
York, New York



time) on the Note  Maturity  Date or,  in the event  that some  shares of Common
Stock  first can be  purchased  under  this  warrant on the Note  Maturity  Date
because the Note Maturity Date occurs prior to the third anniversary of the date
hereof,  on the date that is 30 days after the Note Maturity Date (the "Exercise
Period").

         The rights  represented  by this  warrant may be  exercised  by (a) the
surrender of this  warrant,  along with the purchase  form attached as Exhibit A
(the  "Purchase  Form"),  properly  executed,  at the address of the Company set
forth in section  7.2 (or such other  address as the Company  may  designate  by
notice in writing to the Holder at its address set forth in section 7.2) and (b)
the payment to the Company of the exercise price by check,  payable to the order
of the  Company,  for the  number of shares of  Common  Stock  specified  in the
Purchase Form,  together with any applicable stock transfer taxes. A certificate
representing  the shares of Common  Stock so  purchased  and, in the event of an
exercise of fewer than all the rights represented by this warrant, a new warrant
in the form of this warrant issued in the name of the Holder or its  designee(s)
and  representing  a new warrant to purchase a number of shares of Common  Stock
equal to the  number  of shares of Common  Stock as to which  this  warrant  was
theretofore  exercisable  less the number of shares of Common  Stock as to which
this warrant shall  theretofore  have been exercised,  shall be delivered to the
Holder or such  designee(s)  as promptly as  practicable,  but in no event later
than three business days, after this warrant shall have been so exercised.

         2. Antidilution. In case the Company shall (i) pay a dividend in shares
of Common Stock or make a distribution in shares of Common Stock, (ii) subdivide
its outstanding shares of Common Stock (including, without limitation, by way of
stock splits and the like), (iii) combine its outstanding shares of Common Stock
into  a  smaller   number  of   shares  of  Common   Stock  or  (iv)   issue  by
reclassification  of its shares of Common Stock other  securities of the Company
(including  any such  reclassification  in connection  with a  consolidation  or
merger in which the Company is the surviving corporation),  the number of shares
of Common Stock  purchasable  upon  exercise of this warrant  immediately  prior
thereto  shall be adjusted  so that the Holder  shall be entitled to receive the
number of shares of Common Stock or the kind and number of other  securities  of
the Company which it would have owned or have been entitled to receive after the
happening of any of the events  described  above had this warrant been exercised
immediately prior to the happening of such event or any record date with respect
thereto,  and the exercise price per share shall be adjusted  appropriately.  An
adjustment  made pursuant to this Section 2 shall become  effective  immediately
after the effective  date of each such event  retroactive to the record date, if
any,  for  such  event,  without  amendment  or  modification  required  to this
document.

         3. Transfer.  Subject to applicable law (including the requirements set
forth in the legend at the  beginning  of this  warrant),  this  warrant  may be
transferred  at any time,  in whole or in part,  to any person or  persons.  Any
transfer shall be


                                        2

effected by the  surrender of this  warrant,  along with the form of  assignment
attached  as Exhibit B,  properly  executed,  at the  address of the Company set
forth in section  7.2 (or such other  address as the Company  may  designate  by
notice in  writing  to the  Holder at its  address  set forth in  section  7.2).
Thereupon,  the Company shall issue in the name or names specified by the Holder
a new warrant or warrants of like tenor and  representing  a warrant or warrants
to purchase in the aggregate a number of shares equal to the number of shares to
which this warrant was theretofore  exercisable  less the number of shares as to
which this warrant shall theretofore have been exercised.

         4. Payment of Taxes. The Company shall cause all shares of Common Stock
issued upon the  exercise of this warrant to be validly  issued,  fully paid and
nonassessable  and not subject to preemptive  rights.  The Company shall pay all
expenses in connection with, and all taxes and other  governmental  charges that
may be imposed  with respect to the issuance or delivery of the shares of Common
Stock upon exercise of this warrant, unless such tax or charge is imposed by law
upon the Holder.

         5. Reservation of Shares. From and after the date of this warrant,  the
Company  shall at all times  reserve and keep  available  for issuance  upon the
exercise  of this  warrant a number of its  authorized  but  unissued  shares of
Common Stock sufficient to permit the exercise in full of this warrant.

         6. Substitution of Preferred Stock.  Notwithstanding  the references in
this  Agreement  to Common  Stock and the  purchase  of  Common  Stock  upon the
exercise of this  warrant,  to the extent the Company is not  permitted to issue
Common Stock without obtaining Stockholder Approval (as defined below) under the
rules or regulations of the Nasdaq Stock Market,  as in effect at the applicable
time, the Company shall  substitute,  in lieu of Common Stock, a preferred stock
of the Company  that (i) shall be  equivalent  to Common  Stock in all  economic
respects,  including with respect to  liquidation,  dividends and other economic
terms,  (ii) shall be non-voting in the event that the holder (together with all
of its  affiliates) is the  beneficial  owner (as such term is defined under the
federal  securities laws and the rules and  regulations  thereunder) of 19.9% or
more of the Common  Stock but  otherwise  shall vote with the Common  Stock as a
single class and be entitled to the same number of votes per share as the number
of shares of Common Stock issuable upon conversion of such preferred  stock, and
(iii) shall be convertible into Common Stock, provided that the conversion right
may not be exercised without  Stockholder  Approval in the event that the holder
(together with all of its affiliates) is, or following such conversion would be,
the  beneficial  owner  of  19.9%  or more  of the  Common  Stock.  "Stockholder
Approval"  means  any  approval  of  stockholders  of the  Company  which may be
required,  in the  reasonable  determination  of the Company  upon advice of its
counsel, under the rules or regulations of the Nasdaq Stock Market, as in effect
at the applicable time.



                                        3

         7.  Miscellaneous.

         7.1  Securities Act  Restrictions.  The Holder  acknowledges  that this
warrant and Common Stock  issuable  upon the exercise of this warrant may not be
sold,  transferred  or  otherwise  disposed  of without  registration  under the
Securities  Act of 1933, as amended (the "Act") or an applicable  exemption from
the registration requirements of the Act and, accordingly,  this warrant and all
certificates  representing  the Common Stock  issuable upon the exercise of this
warrant shall bear a legend in the form set forth on the top of page one of this
warrant.

         7.2 Notices.  Any notices and other  communications  under this warrant
shall  be in  writing  and may be  given by any of the  following  methods:  (a)
personal delivery; (b) facsimile transmission; (c) registered or certified mail,
postage prepaid,  return receipt  requested;  or (d) overnight delivery service.
Notices  shall be sent to the  appropriate  party at its  address  or  facsimile
number given below (or at such other address or facsimile  number for such party
as shall be specified by notice given hereunder):  (a) if to the Company,  to it
at: 2000  Pennsylvania  Avenue,  Washington,  DC 20006,  Fax No. (202) 822-8984,
Attention:  Chief  Executive  Officer,  and if to the  Holder,  to it at his/her
address  appearing on the stock records of the Company at the time that a notice
shall be mailed, or at such other address as the party to be notified shall from
time to time have furnished to the Company.  All such notices and communications
shall be deemed received upon (a) actual receipt  thereof by the addressee,  (b)
actual  delivery  thereof  to the  appropriate  address  or (c) in the case of a
facsimile transmission,  upon transmission thereof by the sender and issuance by
the  transmitting  machine of a confirmation  slip confirming that the number of
pages  constituting the notice have been transmitted  without error. In the case
of notices sent by facsimile  transmission,  the sender shall  contemporaneously
mail a copy of the notice to the  addressee  at the address  provided for above.
However,  such  mailing  shall in no way alter  the time at which the  facsimile
notice is deemed received.

         7.3  Amendment.  This  warrant  may  be  modified  or  amended  or  the
provisions  of this  warrant may be waived only with the written  consent of the
Company and the Holder.

                                        4

         7.4  Governing  Law.  This warrant  shall be governed by the law of the
State  of  Delaware,  without  regard  to the  provisions  thereof  relating  to
conflicts of laws.

                                      EGLOBE, INC.

                                       By:
                                            ------------------------------
                                            Name:   Christopher J. Vizas
                                            Title:  Chairman of the Board of
                                                      Directors and Chief
                                                      Executive Officer

                                       5

                                    EXHIBIT A

                                  PURCHASE FORM

         EXTL Investors,  LLC, the undersigned registered owner of this warrant,
irrevocably  exercises this warrant for the purchase of ______________ shares of
common stock,  $.001 par value per share (the "Common  Stock") of eGlobe,  Inc.,
for a price per share equal to $1.00, and herewith makes payment therefor in the
aggregate amount of $___________,  all on the terms and conditions  specified in
this  warrant,  and requests  that  certificates  for the shares of Common Stock
hereby purchased be issued in the name of and delivered to the undersigned.

Dated:                                   EXTL Investors, LLC
       ----------------------
                                         By
                                              --------------------------------
                                        Title
                                              --------------------------------
                                        Address
                                              --------------------------------


                                       6

                                    EXHIBIT B

                                 ASSIGNMENT FORM

         FOR VALUE RECEIVED.  the undersigned  registered  owner of this warrant
hereby  sells,  assigns and  transfers  to the  assignee  named below all of the
rights of the  undersigned  under  this  warrant  with  respect to the number of
shares of common  stock,  $.001 par value per share of  eGlobe,  Inc.  set forth
below:

      Name and Address of Assignee           No.  of Shares of Common Stock
      ----------------------------           ---  -------------------------

and  does  hereby  irrevocably   constitute  and  appoint   ____________________
attorney-in-fact  to  register  such  transfer  on the  books  of  eGlobe,  Inc.
maintained for the purpose, with full power of substitution in the premises.

Dated:                          Print Name:
- ------------------------                      --------------------------------
                                Signature:
                                              --------------------------------
                                Witness:
                                              --------------------------------



                                       7